VC
Vivo Capital Portfolio holdings
AUM
$977M
1-Year Return
209.68%
This Quarter Return
-5.46%
1 Year Return
+209.68%
3 Year Return
+1,480.07%
5 Year Return
+2,591.98%
10 Year Return
–
AUM
$1.1B
AUM Growth
-$269M
(-20%)
Cap. Flow
-$269M
Cap. Flow
% of AUM
-24.35%
Top 10 Holdings %
Top 10 Hldgs %
61.03%
Holding
57
New
53
Increased
–
Reduced
–
Closed
4
Top Buys
| 1 |
Ascendis Pharma
ASND
|
+$226M |
| 2 |
NFH
New Frontier Health Corporation Ordinary Shares
NFH
|
+$118M |
| 3 |
KDMN
Kadmon Holdings, Inc.
KDMN
|
+$52.5M |
| 4 |
Arcutis Biotherapeutics
ARQT
|
+$50.3M |
| 5 |
Crinetics Pharmaceuticals
CRNX
|
+$48.8M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 87.06% |
| 2 | Financials | 10.69% |
| 3 | Materials | 1.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Rocket Pharmaceuticals
RCKT
$341M
| $12M | 1.09% |
+860,648
| New | +$12M |
|
27
Kiniksa Pharmaceuticals
KNSA
$2.75B
| $11.8M | 1.06% |
+759,050
| New | +$11.8M |
|
|
TCDA
28
DELISTED
Tricida, Inc. Common Stock
TCDA
| $11.5M | 1.04% |
+524,290
| New | +$11.5M |
|
29
Zai Lab
ZLAB
$3.65B
| $11.4M | 1.04% |
+222,107
| New | +$11.4M |
|
30
KalVista Pharmaceuticals
KALV
$708M
| $11.3M | 1.02% |
+1,476,796
| New | +$11.3M |
|
|
IGMS
31
DELISTED
IGM Biosciences
IGMS
| $11.2M | 1.02% |
+199,626
| New | +$11.2M |
|
|
TECX
32
Tectonic Therapeutic, Inc. Common Stock
TECX
$332M
| $11.2M | 1.01% |
+59,813
| New | +$11.2M |
|
33
VYNE Therapeutics
VYNE
$7.91M
| $10.3M | 0.93% |
+53,386
| New | +$10.3M |
|
|
TRIL
34
DELISTED
Trillium Therapeutics Inc.
TRIL
| $8.3M | 0.75% |
+2,054,468
| New | +$8.3M |
|
35
Collegium Pharmaceutical
COLL
$1.18B
| $7.3M | 0.66% |
+447,173
| New | +$7.3M |
|
36
Aurinia Pharmaceuticals
AUPH
$1.68B
| $7.27M | 0.66% |
+500,732
| New | +$7.27M |
|
37
KALA BIO
KALA
$131M
| $6.92M | 0.63% |
+15,753
| New | +$6.92M |
|
38
Matinas BioPharma
MTNB
$10.2M
| $6.77M | 0.61% |
+225,586
| New | +$6.77M |
|
39
Black Diamond Therapeutics
BDTX
$185M
| $6.29M | 0.57% |
+252,119
| New | +$6.29M |
|
|
VRNA
40
Verona Pharma
VRNA
$9.21B
| $6.15M | 0.56% |
+1,492,951
| New | +$6.15M |
|
41
Soleno Therapeutics
SLNO
$2.85B
| $4.81M | 0.44% |
+134,758
| New | +$4.81M |
|
|
CHMA
42
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $4.64M | 0.42% |
+1,272,156
| New | +$4.64M |
|
43
Xenon Pharmaceuticals
XENE
$2.79B
| $4.5M | 0.41% |
+396,589
| New | +$4.5M |
|
|
CNST
44
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $4.41M | 0.4% |
+140,298
| New | +$4.41M |
|
45
Revolution Medicines
RVMD
$8.7B
| $4.37M | 0.4% |
+199,518
| New | +$4.37M |
|
46
Galmed Pharmaceuticals
GLMD
$8.27M
| $2.98M | 0.27% |
+4,778
| New | +$2.98M |
|
47
AtriCure
ATRC
$1.74B
| $2.17M | 0.2% |
+64,573
| New | +$2.17M |
|
48
Aclaris Therapeutics
ACRS
$211M
| $1.71M | 0.16% |
+1,647,214
| New | +$1.71M |
|
|
CBAY
49
DELISTED
Cymabay Therapeutics
CBAY
| $1.6M | 0.14% |
+1,077,467
| New | +$1.6M |
|
50
uniQure
QURE
$904M
| $1.09M | 0.1% |
+22,932
| New | +$1.09M |
|